Caspase detection protocol

Caspases are essential in cells for apoptosis, one of the main types of programmed cell death in development and most other stages of adult life, and have been termed "executioner" proteins for their roles in the cell. Caspases were first implicated in apoptosis when CED-3, a protein required for programmed cell death in Caenorhabditis elegans, was found to have close homology with the mammalian interleukin-1
-converting enzyme (ICE or caspase 1) and that over-expression of ICE induced apoptosis. Failure of apoptosis is one of the main causes of tumour development and autoimmune diseases. This coupled with the unwanted apoptosis that occurs with ischaemia or Alzheimer's disease, has raised interest in caspases as potential therapeutic targets. Caspases are enzymes known as proteases, which play essential roles in apoptosis and inflammation. As proteases, they are enzymes that cleave other proteins. They are called cysteine proteases, because they use a cysteine residue to cut those proteins, and called caspases because the cysteine residue cleaves their substrate proteins at the aspartic acid residue. The generic name for all members is caspase with the c denoting a cysteine protease and aspase referring to the aspartate specific cleaving ability of these enzymes. The individual members are then numbered according to their chronological order of publication. To date 14 caspases have been identified (12 human and 2 murine).